PIPEs
Baring Asia invests $100m in Hutchison China MediTech
Baring Private Equity Asia has invested $100 million in Hutchison China MediTech (HutchMed), a US and London-listed drug discovery business that has two fully commercialized oncology products in China.
IMM set for $222m exit from Korea's Taihan Electric Wire
IMM Private Equity has agreed to sell its 40% stake in Taihan Electric Wire, a Korea-based manufacturer of high-voltage cables to Hoban Construction for KRW251.8 billion ($222 million).
Novo Tellus backs Singapore semiconductor industry supplier
Novo Tellus Capital Partners has invested S$23.6 million ($17.7 million) in Grand Venture Technology, a Singapore-listed provider of testing, assembly, and engineering services for semiconductor manufacturing.
Silver Lake joins $3.3b investment in China's TAL Education
Silver Lake has led a $2.3 billion investment in TAL Education Group, a US-listed Chinese after-school education provider, via a convertible notes issue.
MBK credit fund to join PE fund on CAR investor roster
MBK Partners has agreed to subscribe to $175 million in convertible bonds issued by China Auto Rental (CAR). It follows a large commitment and a take-private offer by MBK last month.
MBK invests $228m in China Auto Rental
MBK Partners has agreed to invest HK$1.8 billion ($228.3 million) in Hong Kong-listed China Auto Rental (CAR), taking a 20.9% stake.
PE & Asian banks: Once-in-a-decade opportunity
GPs like targeting banks during downturns, investing in stronger players at discount valuations and backing them to come out the other side with increased market share. Will it be more of the same with COVID-19?
PAG poised to invest in Australian airline
PAG Asia Capital is in exclusive negotiations over a A$150 million ($109 million) investment in Regional Express Holdings (Rex), an Australian airline that emerged following the collapse of Ansett Airlines.
Deal focus: Affinity, Baring leverage market dislocation
Seeing Korean banks trading at discounted valuations and believing in the long-term health of the industry, some private equity investors have taken the opportunity to buy in the public markets
GPs join $516m investment in Evergrande's EV unit
Evergrande New Energy Vehicle (NEV), a subsidiary of Chinese real estate developer Evergrande Group, has raised HK$4 billion ($516 million) from investors including Tencent Holdings, Sequoia Capital China, Yunfeng Capital, and Didi Chuxing.
DCP invests $283m in Chinese diabetes treatment player
DCP Capital Partners has acquired a 9% stake in Tonghua Dongbao Pharmaceutical, a Chinese pharmaceutical company specializing in diabetes treatment, for RMB1.94 billion ($283.7 million).
Hillhouse leads $418m investment in China's I-Mab
I-Mab Biopharma, a private equity-backed Chinese drug developer that listed in the US as recently as January, has raised $418 million through a private placement.
Carlyle invests $260m in China's Salubris Pharmaceutical
The Carlyle Group has paid about $260 million for a 5% stake in Shenzhen-listed Salubris Pharmaceutical.
Baring Asia leads $209m round for India’s RBL Bank
A consortium of investors led by Baring Private Equity Asia will invest INR15.6 billion ($209 million) for a 19.55% stake in listed Indian lender RBL Bank.
WestBridge invests $75m in India’s IndiGo
India-focused WestBridge Capital has invested INR5.5 billion ($75 million) in budget airline operator IndiGo.
PAI Capital invests $212m in Chinese video display business
PAI Capital, a Hong Kong and London-based asset manager that primarily caters to high net worth individuals (HNWIs), has paid RMB1.45 billion ($212 million) for a 24.22% stake in Vtron Group, a Shenzhen-listed video display systems manufacturer.
Deal focus: KKR's Vietnam macro proxy - update
KKR - working alongside Temasek Holdings - is using Vinhomes as a means to get exposure to Vietnam's booming property market. Mergermarket and AVCJ offer some additional industry context
Hillhouse invests $1.5b in Chinese EV battery maker
Hillhouse Capital has invested RMB10.6 billion ($1.5 billion) in Chinese electric vehicle (EV) battery manufacturer Contemporary Amperex Technology (CATL). It is part of a RMB19.7 billion capital raise by the Shenzhen-listed company.
General Atlantic invests $100m in Chinese drug maker
General Atlantic has invested $100 million in NASDAQ-listed Chinese cancer drug developer Hutchison China MediTech - also known as Chi-Med - a subsidiary of Hong Kong conglomerate CK Hutchison Holdings.
Hillhouse invests $400m in China data center player
Hillhouse Capital has taken a 3.9% interest in US-listed Chinese data center developer GDS Holdings for $400 million.
Blackstone invests $150m in China's 21Vianet
The Blackstone Group has invested $150 million in 21Vianet, a US-listed Chinese data center developer backed by Singapore’s Temasek Holdings.
Carlyle invests $198m in Korea's KB Financial
The Carlyle Group has invested KRW240 billion ($198 million) in KB Financial Group and agreed to work with the Korean company on investment opportunities and structuring and financing its deals in the country.
KKR, Temasek commit $650m to Vietnam property developer
A consortium led by KKR has invested VND15.1 trillion ($650 million) in Vinhomes, Vietnam’s leading integrated real estate developer, which went public in 2018.
CVC seeks control of India healthcare player HCG
CVC Capital Partners is looking to acquire majority control of Indian cancer care center operator HealthCare Global Enterprises (HCG) in a deal that could be worth up to IN10.4 billion ($$138.9 million).
